Annovis Bio closes $3M equity offering of 316,455 shares at $9.48/share

Annovis Bio, Inc.

Raised $3,000,000 gross proceeds from sale of 316,455 common shares at $9.48 per share to an institutional investor.
Offering closed on March 22, 2024, under effective shelf registration statement on Form S-3 (No. 333-276814).
Securities Purchase Agreement signed March 21, 2024; shares issued directly without a placement agent.
Proceeds expected for general corporate purposes; dilution of ~3.2% based on prior outstanding shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.